| Zum Hauptmenu. | Zum Bereichsmenu. | Zur Metanavigation. | Zur Suche. | Direkt zum Inhalt.
Wacker Chemie AG confirmed its positive 2007 sales and earnings forecast at the first Annual Shareholder Meeting since its April 2006 IPO.
Eurofins Medigenomix GmbH / MWG Biotech AG have finalised a genome sequencing project with Wacker Chemie AG for the analysis of the genetic differences between WACKER’s proprietary industrial protein production E. coli strain and its corresponding parental strain.
Munich-based Wacker Chemie AG is participating in an initiative launched by the German Deutsche Energie Agentur GmbH (dena) and the Chinese Ministry of Construction (MoC) to support and promote the construction and renovation of climate-adapted and energy-efficient buildings in China.
Wacker Chemie AG remained on course for growth in Q1 2007. With the positive economic trend set to continue, the Munich-based chemical company has substantially expanded its manufacturing output and sales volumes.
Under the slogan “Innovation by Passion,” the Munich-based WACKER Group will be presenting a whole range of innovative product solutions at the European Coatings Show (ECS) in Nuremberg from May 8-10.